The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Completion of Acquisition of BoardEx and The Deal

14 Feb 2019 07:54

RNS Number : 9973P
Euromoney Institutional InvestorPLC
14 February 2019
 

 

EUROMONEY INSTITUTIONAL INVESTOR PLC

ACQUISITION OF BOARDEX AND THE DEAL

14 February 2019

Euromoney completes the acquisition of BoardEx and The Deal

 

Euromoney Institutional Investor PLC ("Euromoney"), the global business information and events group, announces that it has today completed the acquisition of The Deal, LLC, comprising BoardEx and The Deal, from its parent company, TheStreet, Inc. on the terms set out in its announcement of 6 December 2018.

 

Ends

For further information, please contact:

Euromoney Institutional Investor PLC

Wendy Pallot, Chief Financial Officer, Euromoney: +44 (0)20 7779 8866; wendy.pallot@euromoneyplc.com

FTI Consulting

Charles Palmer / Jamie Ricketts / Amy Hurnell / Jamille Smith: +44 20 3727 1000; euromoney@fticonsulting.com 

About Euromoney Institutional Investor PLC

Euromoney is a global information business providing essential B2B information to global and specialist markets. Euromoney provides price discovery, market intelligence and events across our segments. Euromoney is listed on the London Stock Exchange and is a member of the FTSE 250 share index.

www.euromoneyplc.com 

 

LEI number: 213800PZU2RGHMHE2S67

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQTIMRTMBIBMLL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.